Reduced cyclosporine exposure is safe and efficacious in combination with basiliximab, enteric-coated mycophenolate-sodium, and steroids.

被引：0
|
作者：
Budde, K
Bosmans, JL
Sennesael, J
Zeier, M
Hopt, U
Fischer, W
Sandau, K
Neumayer, HH
机构：
[1] Charite, Berlin, Germany
[2] Univ Ziekenhuis, Antwerp, Belgium
[3] Ziekenhuis Vrije Univ, Brussels, Belgium
[4] Univ Heidelberg, Heidelberg, Germany
[5] Univ Freiburg, Freiburg, Germany
[6] Novartis, Nurnberg, Germany
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2005年 / 5卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
1195
引用
收藏
页码：461 / 461
页数：1
相关论文
共 50 条
  • [1] Reduced-exposure cyclosporine is safe and efficacious in de novo renal transplant recipients treated with enteric-coated mycophenolic acid and basiliximab
    Budde, K.
    Bosmans, J.-L.
    Sennesael, J.
    Zeier, M.
    Pisarski, P.
    Schuetz, M.
    Fischer, W.
    Neumayer, H.-H.
    Glander, P.
    [J]. CLINICAL NEPHROLOGY, 2007, 67 (03) : 164 - 175
  • [2] Enteric-coated mycophenolate sodium in combination with full dose or reduced dose cyclosporine, basiliximab and corticosteroids in Australian de novo kidney transplant patients
    Chadban, Steve
    Eris, Josette
    Russ, Graeme
    Campbell, Scott
    Chapman, Jeremy
    Pussell, Bruce
    Trevillian, Paul
    Ierino, Francesco
    Thomson, Napier
    Hutchison, Brian
    Irish, Ashley
    Woodcock, Chad
    Kurstjens, Nicol
    Walker, Rowan
    [J]. NEPHROLOGY, 2013, 18 (01) : 63 - 70
  • [3] Enteric-coated mycophenolate-sodium in heart transplantation: Efficacy, safety, and pharmacokinetic compared with mycophenolate mofetil
    Lehmkuhl, H.
    Hummel, M.
    Kobashigawa, J.
    Ladenburger, S.
    Rothenburger, M.
    Sack, F.
    Dengler, T.
    Hetzer, R.
    [J]. TRANSPLANTATION PROCEEDINGS, 2008, 40 (04) : 953 - 955
  • [4] ENTERIC COATED MYCOPHENOLATE SODIUM WITH BASILIXIMAB INDUCTION, TACROLIMUS WITH OR WITHOUT STEROIDS IS SAFE AND EFFECTIVE IN ADULT LIVER TRANSPLANTATION
    Ramirez, Carlo B.
    Doria, Cataldo
    Frank, Adam M.
    Navarro, Victor
    Herrine, Steven
    Rossi, Simona
    Chaballa, Mark
    Vaccino, Silvia
    Kang, Yoogoo
    Marino, Ignazio R.
    [J]. LIVER TRANSPLANTATION, 2008, 14 (07) : S109 - S109
  • [5] Tolerability of enteric-coated mycophenolate sodium to 1 year in combination with cyclosporine and corticosteroids in renal transplant recipients
    Rostaing, L.
    Mourad, G.
    Kamar, N.
    Garrigue, V.
    Karras, A.
    Lefrancois, N.
    Charpentier, B.
    Bourbigot, B.
    Pouteil-Noble, C.
    Bayle, F.
    Lebranchu, Y.
    Berthoux, F.
    Le Meur, Y.
    Kessler, M.
    Moulin, B.
    Ducloux, D.
    Delahousse, M.
    Lang, P.
    Merville, P.
    Chaouche-Teyara, K.
    Legendre, C.
    [J]. TRANSPLANTATION PROCEEDINGS, 2006, 38 (09) : 2860 - 2863
  • [6] Enteric-coated mycophenolate sodium delivers bioequivalent MPA exposure compared with mycophenolate mofetil
    Arns, W
    Breuer, S
    Choudhury, S
    Taccard, G
    Lee, J
    Binder, V
    Roettele, J
    Schmouder, R
    [J]. CLINICAL TRANSPLANTATION, 2005, 19 (02) : 199 - 206
  • [7] Cyclosporine Sparing Effect of Enteric-Coated Mycophenolate Sodium in De Novo Kidney Transplantation
    Lee, Su Hyung
    Park, Jae Berm
    Oh, Chang-Kwon
    Kim, Myoung Soo
    Kim, Sung Joo
    Ha, Jongwon
    [J]. YONSEI MEDICAL JOURNAL, 2017, 58 (01) : 217 - 225
  • [8] CYCLOSPORINE SPARING EFFECT OF ENTERIC-COATED MYCOPHENOLATE SODIUM IN DE NOVO KIDNEY TRANSPLANTATION
    Oh, Chang-Kwon
    Lee, Su Hyung
    Kim, Myoung Soo
    Kim, Sung Joo
    Ha, Jongwon
    [J]. TRANSPLANT INTERNATIONAL, 2015, 28 : 374 - 374
  • [9] Enteric-coated mycophenolate sodium: Safe conversion from mycophenolate mofetil in maintenance renal transplant recipients
    Budde, K
    Glander, P
    Diekmann, F
    Dragun, D
    Waiser, J
    Fritsche, L
    Neumayer, HH
    [J]. TRANSPLANTATION PROCEEDINGS, 2004, 36 (02) : 524S - 527S
  • [10] Significant pharmacokinetic differences between mycophenolate mofetil and enteric-coated mycophenolate sodium (EC-MPS) in stable renal transplant patients treated with tacrolimus without steroids.
    Puig, J. M.
    Mir, M.
    Marin, M.
    Ferrer, M.
    Barrios, C.
    Barbosa, F.
    Vazquez, S.
    Rodriguez, E.
    Lloveras, J.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 349 - 349
12345